학술논문

Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene
Document Type
Letter
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 2024, 65(1):123-127)
Subject
Language
English
ISSN
10292403
10428194